Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Amphastar Pharmaceuticals Inc., 3 years.
Amphastar Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Amphastar Pharmaceuticals Inc. June 3, 202472.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Amphastar Pharmaceuticals Inc. | Grant or award | +8,143 | — | — |
| Jun 2, 2025 | Amphastar Pharmaceuticals Inc. | Grant or award | +5,122 | — | — |
| Jun 3, 2024 | Amphastar Pharmaceuticals Inc. | Grant or award | +3,076 | — | — |
| Mar 5, 2024 | Amphastar Pharmaceuticals Inc. | Open-market sale | −9,389 | $47.06 | $441,846 |
| Mar 5, 2024 | Amphastar Pharmaceuticals Inc. | Open-market sale | −3,111 | $47.53 | $147,866 |
| Aug 15, 2023 | Amphastar Pharmaceuticals Inc. | Open-market sale | −12,759 | $57.22 | $730,070 |
| Jun 5, 2023 | Amphastar Pharmaceuticals Inc. | Grant or award | +2,716 | — | — |
| May 15, 2023 | Amphastar Pharmaceuticals Inc. | Open-market sale | −7,500 | $42.18 | $316,350 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.